PARC hosts active working groups comprised of clinicians, pre-clinical researchers, and socio-behavioral researchers with the goal of developing written proposals for research funding in the areas of pain and addiction.
PARC’s current working groups focus on professional education across sectors, medication-assisted treatments, and pre-clinical studies of pain and addiction. One group is focused on reducing stigma toward people who use drugs through development and evaluation of a curriculum for professionals in substance use treatment, the judicial-legal system, and healthcare providers. A second group is focused on understanding the most effective practices in the treatment of opioid use disorder (Buprenorphine). A third group is developing pain management teaching modules for healthcare providers across UCSF Health.
Additional groups that are in the process of forming include: examination of pediatric and maternal care outcomes with Buprenorphine versus other treatments; consideration of policy and structural elements that affect access to Buprenorphine; and exploration of the molecular action of Buprenorphine to better understand its unique role in the treatment of opioid use disorder. Please contact PARC if you wish to join a working group or suggest a new one.
Working group members are organized across the following broad categories of interests:
Pre-clinical: Aashish Manglik, Elyssa Margolis, Kevin Yackle, Judith Hellman, Howard Fields, Jarret Weinrich, Prasad Shirvalkar
Best Practices with clinical orientation: Matt Tierney, Scott Steiger, Hannah Snyder, Tricia Wright, Era Kryzhanovskaya, Heidi Reetz, Dominika Seidman, Elizabeth Gatewood, Matthias Behrends, Kathy LeSaint
Community-based and Policy interventions: Kelly Knight, Joanne Spetz, Dan Ciccarone, Jennifer Cocohoba, Dominika Seidman, Diana Coffa, Heidi Reetz, Ulrike Muench
UCSF does not use race, gender, sex, or other protected categories or proxies for protected categories in the selection process.